Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Mustard gas exposure causes hair loss, but treating with N-acetylcysteine can prevent it.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

A hospital outbreak of catheter infections in calves was caused by a bacteria from a beef herd, leading to longer hospital stays, more drug use, and calf deaths.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

ESR2 gene linked to female-pattern hair loss.

STS01 1% effectively promotes hair regrowth with minimal side effects.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

ROS may affect hair loss related to hormones.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Finasteride may cause kidney damage.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Annexin A2 isoform 2 helps dermal papillae cells grow, affecting hair growth.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.